In the latest large M&A deal in the pharmaceutical sector, at least eight firms are advising on the $14.2 billion sale of Merck & Co.’s consumer care business to German drug giant Bayer AG.
The transaction, announced Tuesday, will make Bayer the world’s second-largest consumer health care company should the deal close as expected in the second half of this year. Bayer won an auction for the Merck’s business. The deal will make Bayer one of the top providers of over-the-counter health products and drugs.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
